The aim of the present study was to understand the possible role of the Dihydromyricetin (DHM) in Alzheimer’s disease (AD) rat model through regulation of the AMPK/SIRT1 signaling pathway. Here, SIRT1 is linked to early-onset autosomal dominant Alzheimer disease.